These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35182756)

  • 1. A dosing nomograph for cerebrospinal fluid penetration of meropenem applied by continuous infusion in patients with nosocomial ventriculitis.
    König C; Grensemann J; Czorlich P; Schlemm E; Kluge S; Wicha SG
    Clin Microbiol Infect; 2022 Jul; 28(7):1022.e9-1022.e16. PubMed ID: 35182756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Meropenem in Neurocritical Care Patients: a Prospective Two-Center Study.
    Kumta N; Heffernan AJ; Cotta MO; Wallis SC; Livermore A; Starr T; Wong WT; Joynt GM; Lipman J; Roberts JA
    Antimicrob Agents Chemother; 2022 Aug; 66(8):e0014222. PubMed ID: 35862757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal penetration of meropenem and vancomycin administered by continuous infusion in patients suffering from ventriculitis-a retrospective analysis.
    Mader MM; Czorlich P; König C; Fuhrmann V; Kluge S; Westphal M; Grensemann J
    Acta Neurochir (Wien); 2018 Nov; 160(11):2099-2105. PubMed ID: 30242495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid penetration of meropenem in neurocritical care patients with proven or suspected ventriculitis: a prospective observational study.
    Blassmann U; Roehr AC; Frey OR; Vetter-Kerkhoff C; Thon N; Hope W; Briegel J; Huge V
    Crit Care; 2016 Oct; 20(1):343. PubMed ID: 27776537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of continuous-infusion meropenem for the treatment of Serratia marcescens ventriculitis in a pediatric patient.
    Cies JJ; Moore WS; Calaman S; Brown M; Narayan P; Parker J; Chopra A
    Pharmacotherapy; 2015 Apr; 35(4):e32-6. PubMed ID: 25884534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics and dosing simulations of total and unbound temocillin in the plasma and CSF of neurocritically ill patients with external ventricular drain-related cerebral ventriculitis.
    Ngougni Pokem P; Liu X; Parker SL; Verroken A; Collienne C; Finet P; Wijnant GJ; Laterre PF; Roberts JA; Van Bambeke F; Wittebole X
    J Antimicrob Chemother; 2024 Feb; 79(2):429-442. PubMed ID: 38153240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population Pharmacokinetics Analysis and Dosing Simulations Of Meropenem in Critically Ill Patients with Pulmonary Infection.
    Lan J; Wu Z; Wang X; Wang Y; Yao F; Zhao BX; Wang Y; Chen J; Chen C
    J Pharm Sci; 2022 Jun; 111(6):1833-1842. PubMed ID: 35090867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meropenem pharmacokinetics in cerebrospinal fluid: comparing intermittent and continuous infusion strategies in critically ill patients-a prospective cohort study.
    Wicha SG; Kinast C; Münchow M; Wittova S; Greppmair S; Kunzelmann AK; Zoller M; Paal M; Vogeser M; Habler K; Weig T; Terpolilli N; Heck S; Dimitriadis K; Scharf C; Liebchen U
    Antimicrob Agents Chemother; 2024 Sep; 68(9):e0045124. PubMed ID: 39082803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population Pharmacokinetics and Pharmacodynamics of Meropenem in Critically Ill Patients: How to Achieve Best Dosage Regimen According to the Clinical Situation.
    O'Jeanson A; Larcher R; Le Souder C; Djebli N; Khier S
    Eur J Drug Metab Pharmacokinet; 2021 Sep; 46(5):695-705. PubMed ID: 34403127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal Fluid Concentrations of Meropenem and Vancomycin in Ventriculitis Patients Obtained by TDM-Guided Continuous Infusion.
    Tiede C; Chiriac U; Dubinski D; Raimann FJ; Frey OR; Röhr AC; Wieduwilt A; Eibach M; Filmann N; Senft C; Zacharowski K; Seifert V; Mersmann J
    Antibiotics (Basel); 2021 Nov; 10(11):. PubMed ID: 34827359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid penetration of fosfomycin in patients with ventriculitis: an observational study.
    König C; Martens-Lobenhoffer J; Czorlich P; Westphal M; Bode-Böger SM; Kluge S; Grensemann J
    Ann Clin Microbiol Antimicrob; 2023 Apr; 22(1):29. PubMed ID: 37095559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics and probability of target attainment of meropenem in critically ill patients.
    Mattioli F; Fucile C; Del Bono V; Marini V; Parisini A; Molin A; Zuccoli ML; Milano G; Danesi R; Marchese A; Polillo M; Viscoli C; Pelosi P; Martelli A; Di Paolo A
    Eur J Clin Pharmacol; 2016 Jul; 72(7):839-48. PubMed ID: 27048201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Plasma and Interstitial Tissue Fluid Pharmacokinetics of Meropenem Demonstrate the Need for Increasing Dose and Infusion Duration in Obese and Non-obese Patients.
    Busse D; Simon P; Schmitt L; Petroff D; Dorn C; Dietrich A; Zeitlinger M; Huisinga W; Michelet R; Wrigge H; Kloft C
    Clin Pharmacokinet; 2022 May; 61(5):655-672. PubMed ID: 34894344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of renal function in risk assessment of target non-attainment after standard dosing of meropenem in critically ill patients: a prospective observational study.
    Ehmann L; Zoller M; Minichmayr IK; Scharf C; Maier B; Schmitt MV; Hartung N; Huisinga W; Vogeser M; Frey L; Zander J; Kloft C
    Crit Care; 2017 Oct; 21(1):263. PubMed ID: 29058601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing Meropenem in Highly Resistant Klebsiella pneumoniae Environments: Population Pharmacokinetics and Dosing Simulations in Critically Ill Patients.
    Truong AQ; Dao XC; Vu DH; Nguyen HA; Do THG; Tran NT; Tran NM; Vu NB; Pham HN; Bui VC; Trinh TA; Dang QT; Nguyen GB; Lipman J; Cotta MO; Roberts JA
    Antimicrob Agents Chemother; 2022 Nov; 66(11):e0032122. PubMed ID: 36197095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic/Pharmacodynamic Analysis of Meropenem for the Treatment of Nosocomial Pneumonia in Intracerebral Hemorrhage Patients by Monte Carlo Simulation.
    Kong L; Tang Y; Zhang X; Lu G; Yu M; Shi Q; Wu X
    Ann Pharmacother; 2017 Nov; 51(11):970-975. PubMed ID: 28677407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population Pharmacokinetics and Pharmacodynamics of Meropenem in Nonobese, Obese, and Morbidly Obese Patients.
    Chung EK; Cheatham SC; Fleming MR; Healy DP; Kays MB
    J Clin Pharmacol; 2017 Mar; 57(3):356-368. PubMed ID: 27530916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population Pharmacokinetics and Dosing Regimen Optimization of Meropenem in Cerebrospinal Fluid and Plasma in Patients with Meningitis after Neurosurgery.
    Lu C; Zhang Y; Chen M; Zhong P; Chen Y; Yu J; Wu X; Wu J; Zhang J
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6619-6625. PubMed ID: 27572392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamics of ceftazidime and meropenem in cerebrospinal fluid: results of population pharmacokinetic modelling and Monte Carlo simulation.
    Lodise TP; Nau R; Kinzig M; Drusano GL; Jones RN; Sörgel F
    J Antimicrob Chemother; 2007 Nov; 60(5):1038-44. PubMed ID: 17785282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal Fluid Penetration of Vancomycin During Continuous Infusion Therapy in Patients With Nosocomial Ventriculitis.
    Tuon FF; Yamada CH; Cieslinski J; Dos Santos Oliveira D; Ribeiro VST; Gasparetto J; Telles JP
    Ther Drug Monit; 2021 Dec; 43(6):807-811. PubMed ID: 34780393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.